Pheochromocytoma and paraganglioma – benefit of combined germline and tumor testing for PPGL patients

Every patient afflicted with a PPGL tumor should be offered genetic testing, since germline mutations are found in 30% of all PPGL patients and in 80% of young PPGL patients. Join this ERN GENTURIS webinar to find out more about the importance of germline and tumour sequencing for these patients and their families.

Clinicians, genetic counsellors, clinical scientists and other genetics health professionals are invited to join.

Book your place on the upcoming webinar via the registration page.